Can ischemic hip disease cause rapidly destructive hip osteoarthritis? A case report

Laroche, Michel; Moineuse, Christine; Durroux, R; Mazières, B; Puget, J.

doi:10.1016/s1297-319x(01)00346-3

Cited by 20 publications

(11 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In fact, AVN and RDA share similar pathologic findings, but whereas the progression of osteonecrosis is gradual, RDA is more rapidly destructive and involves a relatively larger area of the femoral head. 2,7 However, little has been reported on RDA of the humeral head. Tokuya et al 9 presented 1 case of RDA that involved a subchondral insufficiency fracture of the humeral head combined with a fracture of the glenoid.…”

Section: Resultsmentioning

confidence: 99%

Rapidly destructive arthrosis of the shoulder joints: radiographic, magnetic resonance imaging, and histopathologic findings

Kekatpure

Sun

Sim

et al. 2015

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Rapidly destructive arthrosis of the shoulder joints: radiographic, magnetic resonance imaging, and histopathologic findings

Kekatpure

Sun

Sim

et al. 2015

Journal of Shoulder and Elbow Surgery

View full text Add to dashboard Cite

“…All of these studies were retrospective. Fourteen were reported in Asia (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15), six in Europe (16)(17)(18)(19)(20)(21) and three in America (22)(23)(24). In total, 17 detailed patient cases were included (one article reported two cases, see Table 1).…”

Section: Literature Searchmentioning

confidence: 99%

The mysteries of rapidly destructive arthrosis of the hip joint: a systemic literature review

Hu¹,

Zhang²,

Kourkoumelis³

et al. 2020

Ann Palliat Med

View full text Add to dashboard Cite

Rapidly destructive arthrosis (RDA) is considered a rare and poorly diagnosed disease but is now seen more frequently in practice due to ageing populations. The most typical radiological features are flat femoral heads, absence of articular cartilage, subchondral bone destruction and signs of joint effusion.These features could be found on X-ray or magnetic resonance imaging (MRI). Surgeons should consider the presence of RDA when patients show rapid femoral head destruction. The purpose of this study is to review the distinct clinical features and successful treatments which may lead to the diagnosis and early handling of RDA. A comprehensive review of the literature was undertaken using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines with no language restrictions. Overall 23 publications with 17 detailed cases of RDA met the inclusion criteria. We found that the only prevalent factors associated with RDA were: (I) age greater than 60 years; (II) female gender; (III) presence of underlying systemic diseases such as rheumatoid arthritis, diabetes mellitus or systemic lupus erythematosus.Further studies should be conducted to clarify the histopathology and define the diagnosis as well as the treatment.

show abstract

“…Contrary to bone, which is a highly vascular tissue, most of the normal articular [46,47]. Finally, atherosclerosis of intraosseous vessels has been implicated in the pathogenesis of OA [48].…”

Section: Bone Marrow Lesionsmentioning

confidence: 99%

Bisphosphonates as a treatment modality in osteoarthritis

Eriksen

Shabestari²,

Ghouri

et al. 2021

Bone

View full text Add to dashboard Cite

Osteoarthritis (OA) is affecting large proportions of the population worldwide.So far, no effective disease modifying drug has been developed for this disease, limiting the therapeutic options to pain medications, physiotherapy and 9 10 ultimately surgical approaches, mainly joint implant surgery. In vitro and animal studies have demonstrated that bisphosphonates have the potential to become effective modalities for the treatment of OA. This group of pharmacological agents modulate crucial aspects of OA pathogenesis (subchondral bone turnover and loss, bone marrow edema formation, cartilage degeneration and synovitis, and have shown clear efficacy in animal models of OA. Human studies have, however, so far been disappointing with only one of six clinical studies showing clear short-term efficacy. Possible reasons for these discrepancies will be discussed. Osteoarthritis Definition, classification and epidemiologyOsteoarthritis (OA) is defined as a joint disorder characterized by cellular stress and extracellular matrix degradation initiated by micro-and macro-injury that activates maladaptive repair responses including pro-inflammatory pathways of innate immunity. This in turn manifests initially as a molecular derangement, abnormal joint tissue metabolism and subsequently by anatomic and physiologic perturbations [1].These processes can present as cartilage degeneration, increased bone remodeling, and osteophyte formation accompanied by inflammation in joint tissue including synovitis, resulting in pain, and loss of normal joint function [2]. Structure-pain relationships in OA remain difficult to understand, however, because it is often unclear which structures may be contributing to pain in the individual patient. Intraarticular candidates include bone and synovium, though it is worth noting that the amount of pain that pathologies in these tissues explain is small [3] and extra-articular features (e.g. tendinitis and bursitis) may confound associations. Clinically, OA refers to a syndrome of joint pain accompanied by varying degrees of functional limitations and reduced quality of life. At least 242 million people globally have hip/knee OA [4]. In addition, with an ageing population and rising risk factors such as obesity, this prevalence is growing [5]. As a result of the disability caused by OA, the cost to the global economy is significant [6]. Current management of OA involves pharmacological, non-pharmacological and ultimately surgical approaches. Conventional pharmacological treatments have limited efficacy and are associated with a number of side-effects, restricting the number of patients who can use them. New pharmacological therapies for managing

show abstract

Can ischemic hip disease cause rapidly destructive hip osteoarthritis? A case report

Cited by 20 publications

References 7 publications

Rapidly destructive arthrosis of the shoulder joints: radiographic, magnetic resonance imaging, and histopathologic findings

Rapidly destructive arthrosis of the shoulder joints: radiographic, magnetic resonance imaging, and histopathologic findings

The mysteries of rapidly destructive arthrosis of the hip joint: a systemic literature review

Bisphosphonates as a treatment modality in osteoarthritis

Contact Info

Product

Resources

About